REGENXBIO Inc.
RGNX
$6.34
$0.213.43%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -78.93% | 2.03% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -78.93% | 2.03% | |||
| Cost of Revenue | 4.39% | 6.01% | |||
| Gross Profit | -76.18% | -9.69% | |||
| SG&A Expenses | -4.80% | 10.50% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -33.33% | -16.92% | |||
| Total Operating Expenses | 2.03% | 7.10% | |||
| Operating Income | -44.64% | -9.97% | |||
| Income Before Tax | -34.11% | -8.41% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -34.11% | -8.41% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -34.11% | -8.41% | |||
| EBIT | -44.64% | -9.97% | |||
| EBITDA | -47.87% | -10.80% | |||
| EPS Basic | -32.38% | -8.28% | |||
| Normalized Basic EPS | -32.38% | -8.26% | |||
| EPS Diluted | -32.56% | -8.28% | |||
| Normalized Diluted EPS | -32.38% | -8.26% | |||
| Average Basic Shares Outstanding | 1.31% | 0.12% | |||
| Average Diluted Shares Outstanding | 1.31% | 0.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||